CDR-Life, a clinical-stage biotechnology company, is naming Dimitrios Chondros, MD, its new Chief Medical Officer (CMO). In that post, Chondros will oversee clinical development, clinical operations, medical affairs, and translational strategy. CDR-Life Makes Strides in Oncology As this relates to CDR-Life, the company develops highly selective T cell engagers (TCEs) to treat cancer and autoimmune diseases. The company’s first oncology program is now in clinical trials. Currently, CDR-L...